ArticleCurrent molecular medicine2024

Toosendanin Restrains Idiopathic Pulmonary Fibrosis by Inhibiting ZEB1/CTBP1 Interaction.

Xingbin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.